In vitro and in vivo efficacy of non-psychoactive cannabidiol in neuroblastoma

T Fisher, H Golan, G Schiby, S PriChen, R Smoum… - Current oncology, 2016 - mdpi.com
Background: Neuroblastoma (NBL) is one of the most common solid cancers in children.
Prognosis in advanced NBL is still poor despite aggressive multimodality therapy …

Medical use of cannabidiol and impact on cancer cell viability

WM Raup-Konsavage, KE Vrana - Medicinal Usage of Cannabis and …, 2023 - Elsevier
While the use of cannabis for medicinal purposes dates back millennia, recently there has
been a renewed interest in the medical properties of this plant and compounds produced by …

Anti-proliferative and cytotoxic effect of cannabidiol on human cancer cell lines in presence of serum

A Sainz-Cort, C Müller-Sánchez, E Espel - BMC research notes, 2020 - Springer
Objective Cannabinoids are able to reduce tumor growth in xenograft models, but their
therapeutic potential as anti-cancer drugs in humans is unclear yet. In vitro studies of the …

Cannabidiol and other phytocannabinoids as cancer therapeutics

G Nahler - Pharmaceutical Medicine, 2022 - Springer
Preclinical models provided ample evidence that cannabinoids are cytotoxic against cancer
cells. Among the best studied phytocannabinoids, cannabidiol (CBD) is most promising for …

Repurposing cannabidiol as a potential drug candidate for anti-tumor therapies

F Wang, G Multhoff - Biomolecules, 2021 - mdpi.com
In recent years, evidence has accumulated that cannabinoids—especially the non-
psychoactive compound, cannabidiol (CBD)—possess promising medical and …

Cannabidiol (CBD) use in breast cancer chemotherapy

AI Fraguas-Sánchez, A Fernández-Carballido… - Medicinal Usage of …, 2023 - Elsevier
Breast cancer constitutes a major global health problem, as it represents the most frequently
diagnosed carcinoma and the leading cause of cancer death in women worldwide. In the …

Cannabidiol Antiproliferative Effect in Triple-Negative breast Cancer MDA-MB-231 cells is modulated by its physical state and by IGF-1

A D'Aloia, M Ceriani, R Tisi, S Stucchi, E Sacco… - International journal of …, 2022 - mdpi.com
Cannabidiol (CBD) is a non-psychoactive phytocannabinoid that has been discussed for its
safety and efficacy in cancer treatments. For this reason, we have inquired into its use on …

Inhalant cannabidiol impedes tumor growth through decreased tumor stemness and impaired angiogenic switch in NCI-H1437-induced human lung cancer model

ÉL Salles, SE Naeini, H Khodadadi, B Bhandari… - Human Cell, 2023 - Springer
Lung cancer remains the most chronic form of cancer and the leading cause of cancer
mortality in the world. Despite significant improvements in the treatment of lung cancer, the …

Cannabidiol: assessing activity in ovarian and endometrial carcinoma cell lines

S Rush, A Kapur, M Patankar, L Barroilhet - Gynecologic Oncology, 2021 - Elsevier
Objectives: Cancer patients use cannabidiol (CBD) for chemotherapy and cancer symptoms,
though recognition of CBD by and its effect on endometrial cancer (EnC) and epithelial …

Cannabidiol (CBD) in cancer management

K O'Brien - Cancers, 2022 - mdpi.com
Simple Summary Cannabidiol (CBD) is one of the main constituents of the plant Cannabis
sativa. Surveys suggest that medicinal cannabis is popular amongst people diagnosed with …